Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment

M T Mellerup; G W Hahn; Lars K. Poulsen; H Malling

Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment

M T Mellerup, G W Hahn, Lars K. Poulsen, H Malling

126 Citations (Scopus)

Abstract

Allergen-specific immunotherapy is a well-documented treatment for allergic rhinitis, asthma, and allergy to Hymenoptera venoms. The drawbacks of injection immunotherapy are related to the risk of inducing systemic side-effects (especially during the induction phase), the time used to reach the maintenance dose, and the percentage of patients completing the induction phase).

Original language	English
Journal	Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Volume	30
Issue number	10
Pages (from-to)	1423-9
Number of pages	7
ISSN	0954-7894
Publication status	Published - Oct 2000

Keywords

Allergens
Female
Humans
Hypersensitivity
Immunotherapy
Male
Retrospective Studies
Sex Factors

Cite this

Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. / Mellerup, M T; Hahn, G W; Poulsen, Lars K. et al.

In: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, Vol. 30, No. 10, 10.2000, p. 1423-9.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{bce83eb4aece4736b07a113dbad541c7,

title = "Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment",

abstract = "Allergen-specific immunotherapy is a well-documented treatment for allergic rhinitis, asthma, and allergy to Hymenoptera venoms. The drawbacks of injection immunotherapy are related to the risk of inducing systemic side-effects (especially during the induction phase), the time used to reach the maintenance dose, and the percentage of patients completing the induction phase).",

keywords = "Allergens, Female, Humans, Hypersensitivity, Immunotherapy, Male, Retrospective Studies, Sex Factors",

author = "Mellerup, {M T} and Hahn, {G W} and Poulsen, {Lars K.} and H Malling",

year = "2000",

month = oct,

language = "English",

volume = "30",

pages = "1423--9",

journal = "Clinical Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment

AU - Mellerup, M T

AU - Hahn, G W

AU - Poulsen, Lars K.

AU - Malling, H

PY - 2000/10

Y1 - 2000/10

N2 - Allergen-specific immunotherapy is a well-documented treatment for allergic rhinitis, asthma, and allergy to Hymenoptera venoms. The drawbacks of injection immunotherapy are related to the risk of inducing systemic side-effects (especially during the induction phase), the time used to reach the maintenance dose, and the percentage of patients completing the induction phase).

AB - Allergen-specific immunotherapy is a well-documented treatment for allergic rhinitis, asthma, and allergy to Hymenoptera venoms. The drawbacks of injection immunotherapy are related to the risk of inducing systemic side-effects (especially during the induction phase), the time used to reach the maintenance dose, and the percentage of patients completing the induction phase).

KW - Allergens

KW - Female

KW - Humans

KW - Hypersensitivity

KW - Immunotherapy

KW - Male

KW - Retrospective Studies

KW - Sex Factors

M3 - Journal article

C2 - 10998019

SN - 0954-7894

VL - 30

SP - 1423

EP - 1429

JO - Clinical Allergy

JF - Clinical Allergy

IS - 10

ER -

Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment

Abstract

Keywords

Fingerprint

Cite this